Neo Ivy Capital Management Veracyte, Inc. Transaction History
Neo Ivy Capital Management
- $294 Million
- Q3 2024
A detailed history of Neo Ivy Capital Management transactions in Veracyte, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 24,116 shares of VCYT stock, worth $866,729. This represents 0.28% of its overall portfolio holdings.
Number of Shares
24,116Holding current value
$866,729% of portfolio
0.28%Shares
8 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$280 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$278 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$181 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$177 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$152 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.57B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...